Matches in Nanopublications for { ?s ?p "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP188336.RAMk25ZGnRhpXv_EYKpyx2ytgwO58C8Qpcgmb8uCnZIyA130_assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188336.RAMk25ZGnRhpXv_EYKpyx2ytgwO58C8Qpcgmb8uCnZIyA130_provenance.
- assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575156.RAKul1yDhtdJS_m0uRIG3_xRC-2cTjFXs30vRg7hCo6s8130_provenance.